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Validation of a prognostic model 
for adverse perinatal health 
outcomes
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eric A. p. Steegers1 & Anke G. posthumus1
there is a strong association between social deprivation and adverse perinatal health outcomes, but 
related risk factors receive little attention in current antenatal risk selection. to increase awareness 
of healthcare professionals for these risk factors, a model for antenatal risk surveillance and care was 
developed in The Netherlands, called the ‘Rotterdam Reproductive Risk Reduction’ (R4U) scorecard. 
The aim of this study was to validate the R4U-scorecard. This study was conducted using external, 
prospective data from thirty-two midwifery practices, and fifteen hospitals in The Netherlands. 
the main outcome measures were the discrimination of the prognostic models for the probability 
of a pregnant woman developing adverse pregnancy outcomes (babies born preterm or small for 
gestational age), and calibration. We performed cross-validation and updated the model using 
statistical re-estimation of all predictors. 1752 participants were included, of whom 282 (16%) had 
one of the predefined adverse outcomes. The discriminative value of the original scoring system was 
poor [area under the curve (AUC) of 0.58 (95% CI 0.53–0.64)]. The model showed moderate calibration. 
The updated R4U-scorecard showed good generalisability to the validation set but did not alter the 
predictive value [AUC 0.61 (95% CI 0.56–0.66)]. By using external data and by updating the prognostic 
model, we have provided a comprehensive evaluation of the R4U-scorecard. Further improvement in 
classification of high-risk pregnancies is important considering the necessity of early risk detection for 
healthcare professionals to take appropriate actions to prevent these risks from becoming manifest 
problems.
There is a strong association between social deprivation and adverse perinatal health outcomes. This associa-
tion is already present during pregnancy and extends into adulthood, with potentially severe long-term health 
 consequences1–5. In The Netherlands, risk surveillance in antenatal health care traditionally mainly focuses on 
single medical or obstetric risk  factors6. Psychosocial (non-medical) risk factors generally receive little attention. 
To increase awareness among health care professionals for these risk factors, a model for antenatal risk surveil-
lance and care was developed in 2008 in The  Netherlands7. This model, implemented as the ‘Rotterdam Reproduc-
tive Risk Reduction (R4U)’ scorecard (supplementary Fig. 1), estimates the probability that a pregnant woman is 
at increased risk of adverse pregnancy outcomes based on multiple medical, obstetric, and non-medical factors 
(i.e. risk factors related to a person’s socioeconomic status and environment). Additionally, the R4U-scorecard 
is accompanied by recommended decisions for clinicians, such as prioritisation of risk factors, risk-specific care 
pathways, and multidisciplinary  consultations8.
Following its development, the R4U-scorecard was used in the national Healthy Pregnancy 4 All-1 (HP4All-1) 
programme, a Cluster Randomized Controlled Trial (C-RCT). This trial investigated the effectiveness of sys-
tematic risk detection and preventive strategies to reduce adverse perinatal health outcomes in antenatal 
 healthcare8–10. The implementation of the R4U-scorecard into routine care, along with risk-guided care through-
out pregnancy, was feasible. Moreover it had a positive impact on physicians’ behaviour by improving awareness 
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of one of the most common adverse perinatal health outcomes during pregnancy, namely intra-uterine growth 
 restriction7.
We aimed to conduct a comprehensive evaluation of the R4U. We hereto included cross-validation of the 
prognostic model underlying the scorecard and suggest directions for improvement by updating the  model11,12.
Results
Of the 2,269 women who originally participated in the intervention arm of the C-RCT embedded in the HP4All-1 
 programme7, 1752 women (77%) were included in this study. The other participants were excluded because, 
despite being in the intervention arm, they did not undergo antenatal risk surveillance with the R4U-scorecard. 
Among the included pregnancies, 282 (16%) had one of the predefined adverse perinatal health outcomes (i.e. 
baby born preterm or small for gestational age (SGA)). Women with an adverse outcome were more often 
smokers, single mothers, and more often had a net household income below 1,000 euros per month (Table 1).
The median R4U-score was 6 (IQR 4–9). An R4U-score above 16 points (n = 90), was associated with sub-
stantially higher odds of having an adverse pregnancy outcome [OR 3.2 (95% CI 2.1–4.8)]. In the development 
set for the cross validation, the median R4U score was the same as observed in the complete dataset. A high 
score (above 16 points) resulted in a higher odds of having an adverse pregnancy outcome in the development 
set [OR 4.2 (95% CI 2.1–8.1)].
The original scoring system had an AUC of 0.58 (95% CI 0.53–0.64) in the validation set. The model showed 
moderate calibration as evidenced by the calibration plot (Fig. 1).
Table 1.  Patient characteristics, comparing women with and without an adverse pregnancy outcome. SGA 
small for gestational age. A P-value based on chi-square analysis for categorical variables. B Western versus non-
western origin based on maternal country of birth and classified according to Statistics Netherlands. C Low net 













p  valueAN % N %
Maternal characteristics
Age category (years)
 < 20 0 0 13 0.9 0.267
 20–35 206 73.0 1,079 73.4
 > 35 76 27.0 378 25.7
Ethnic origin
 Western 243 86.2 1,301 88.5 0.089
 Non-western 39 13.8 156 10.6
 Missing 0 0.0 13 0.9
Smoking during pregnancy
 Yes 70 24.8 248 16.9 0.005
 No 210 74.5 1,202 81.8
 Missing 2 0.7 20 1.4
Single mother
 Yes 32 11.3 76 5.2 0.001
 No 250 88.7 1,392 94.7
 Missing 0 0.0 2 0.1
Low household income
 Yes 36 12.8 113 7.7 0.013
 No 245 86.9 1,343 91.4
 Missing 1 0.4 14 1.0
BMI at start pregnancy
 BMI < 25 22 7.8 67 4.6 0.073
 BMI 25–35 195 69.1 1,040 70.7
 BMI > 35 65 23.0 363 24.7
Pregnancy characteristics
Parity
Nulliparous 128 45.4 672 45.7 0.920
Multiparous 154 54.6 798 54.3
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Update of the original model in the development set. We selected seven predictors for which the 
R4U score would be updated (Fig. 2). The heuristic shrinkage factor was calculated as 0.45 (assuming 43 degrees 
of freedom). One point increase in R4U-score corresponded with a β-coefficient of 0.06.
Two of the seven predictors, i.e. ‘illicit drug use during the preconception period’ and ‘recurrent miscar-
riages’, had a counterintuitive sign (i.e. a protective effect) and were therefore excluded from the model (Fig. 2).
predictive value of the updated model in the validation set. Updating of the prognostic model with 
regard to the remaining five predictors showed a similar discriminative ability of the R4U score in the validation 
set (AUC 0.61 (95% CI 0.56–0.66) compared to the development set. The updated prognostic model improved 
calibration (Fig. 1). Sensitivity increased from 11 to 23%.
Figure 1.  Calibration plot of the original model and the updated model. Calibration curve comparison between 
the original and the updated model for neonatal morbidities with 95% confidence interval in grey. The y-axis 
represents the observed proportion of high-risk scores (above 16 points). The intercept and slope of the logistic 
regression model are presented together with the c-statistic, indicating the discriminative ability. The diagonal 
red 45-degree line represents perfect prediction by an ideal model. The distribution of participants is indicated 
with spikes at the bottom of the graph, stratified by endpoint (those with neonatal morbidities above the x-axis 
and those without adverse outcomes below the x-axis). Graph: xlim = c(0,.45).
Figure 2.  Updating steps of the prognostic model.
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Discussion
We present an updated R4U-scorecard that is applicable in the first trimester of pregnancy to estimate the risk 
of adverse perinatal health outcomes, based on a comprehensive set of medical, obstetric, and non-medical risk 
factors (supplementary Fig. 1). By using a large external dataset and by applying a stepwise statistical approach 
to update the prognostic model and perform cross-validation, we have provided a comprehensive evaluation of 
this diagnostic  tool12–14.
Our large multicentre prospective cohort included both low- and high-risk pregnancies derived from a 
population in which the model is aimed to be used. We applied domain validation. This is considered to be the 
broadest form of validation, leading to the strongest evidence that the prediction model can be generalised to new 
patients over time. The generalisability was underlined by the predictive value of the model in the validation set. 
A scorecard that is generalizable to new patients makes the subsequent institution of preventive strategies more 
relevant. We present a detailed description of the methodology used to update the prognostic model in several 
distinct steps. Validation studies of antenatal risk surveillance tools that include non-medical risk factors, such 
as a person’s socioeconomic status, are to our knowledge non-existent. The steps we present could be considered 
as a framework, and can be applied in other fields of study based on the elaborate description provided.
There are also several limitations that merit discussion. First, predictors are interconnected making it difficult 
to establish their independent contribution. For example, having a low household income might induce changes 
in one or more other risk factors such as housing conditions, but risk factors such as chronic diseases may also 
reduce labour supply and  earnings15–17. In view of these complex relationships, our estimates and the resulting 
cumulative score, which assumes unidirectional causal associations, should be interpreted with caution.
Second, the development and validation of the models originated from a prospective cohort in The Neth-
erlands, potentially limiting the generalisability outside the Dutch antenatal health care system. Additionally, 
the previously reported degree of selection bias in the C-RCT 7, also applies to the results presented. A generally 
healthy population was included with a lower incidence of adverse pregnancy outcomes than the Dutch national 
average. Importantly, this bias is likely to cause underestimation of the discriminating power of the model.
Thirdly, we made some simplifications for easy clinical application of the R4U-scorecard. For example, all 
predictors and the outcome were dichotomised.
Both calibration and discrimination are useful aspects of a prediction model. However, in general discrimi-
nation is insensitive to errors in calibration, and considers the situation of classification in a pair of participants 
with and without the  endpoint18.
By applying the stepwise statistical approach in order to update the predictors in the scorecard we primarily 
intended to improve calibration.
To further improve clinical decision making with the updated scorecard, a range of thresholds for high and 
low-risk participants could be considered to optimise the discriminative value. It is usually difficult to define 
an optimum threshold as empirical evidence for the relative weights of benefits and harms is often lacking. In 
our example considerations should weigh the potential of early identification of pregnant women at risk and 
the possibility to introduce preventive strategies early in the first trimester of pregnancy, against the potential 
harms of ’over-treatment’.
Moreover, to create a valuable decision tool for antenatal risk surveillance and preventive strategies, a prognos-
tic model alone is not sufficient. Consecutive preventive strategies (e.g. care-pathways) prioritised at addressing 
risk factors with a high relative risk for adverse health outcomes together with comprehensive guidelines for 
preventive strategies for individual risks, need to be available and updated regularly to fit changes in daily clini-
cal practices. Also, updating of the R4U prognostic scoring system may be needed to meet the local population.
Implementation of accurate prognostic models early in pregnancy provides room for preventive strategies 
and embodies potential to change daily practices and reduce early adversity in health outcomes. By updating the 
R4U-scorecard we have amended a clinical tool to guide these actions. Furthermore, we presented a framework 
for updating of a prognostic model with new information while keeping the prior information. This framework 
is relevant for wider implementation of prognostic models in clinical practice.
Methods
Using external data from a national Cluster-Randomised Controlled Trial (C-RCT)7, we performed cross-val-
idation of the R4U-scorecard with re-consideration of the additional effect of all predictors included in the 
scorecard. We then derived an updated version of the R4U-scorecard.
Derivation cohort the healthy pregnancy 4 All-1 programme. The national HP4All-1 programme 
was conducted in The Netherlands from 2011 through  20149. Two sub-studies within the programme combined 
public health and epidemiologic research. The first evaluated the effectiveness of programmatic preconception 
care, and the second evaluated the effectiveness of antenatal risk assessment with consecutive risk-guided care 
throughout  pregnancy8,19.
The antenatal risk assessment sub-study. The antenatal risk assessment sub-study was conducted as a 
C-RCT aiming to reduce adverse pregnancy outcomes by implementing a complex  intervention7. The complex 
intervention consisted of three parts; (1) a first trimester risk surveillance using the R4U-scorecard, assessing 
both medical and non-medical risk factors known to be associated with adverse perinatal health outcomes (sup-
plementary Fig. 1); (2) subsequent application of risk-specific care pathways; and (3) multidisciplinary consulta-
tion between care professionals from different echelons to discuss high-risk cases (e.g. health care organisations, 
public health care organisations, the office for legal or financial support).
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Randomisation in this study took place at the level of the clusters, consisting of community midwifery prac-
tices or obstetric departments in hospitals. In the intervention arm, identification of specific risk factors implied 
a follow-up action such as tailoring care using risk-specific care pathways. In the control clusters, conventional 
obstetric care was provided. This consisted of screening by means of the ‘list of obstetric indications’ (LOI), 
which focuses on identification of single, manifest obstetric and medical risks, combined with individual care 
according to local protocols of obstetric care  givers6.
The data from this C-RCT was used as external data to update the R4U-scorecard that was originally piloted 
in several hospitals and midwifery practices in Rotterdam from 2010 until  201120.
The R4U-scorecard. The primary basis for the R4U-scorecard was a simple scoring system in which all 
components had been selected and scores assigned both subjectively by expert consensus and objectively using 
available scientific literature, as described  previously10.
Seventy-nine medical and non-medical dichotomised variables were incorporated in the R4U-scorecard, of 
which 76 pertain to the first trimester (supplementary Fig. 1). Key examples of non-medical risk factors include: 
low socioeconomic status, living in a deprived neighbourhood, ineffective social integration into society, and 
smoking.
Two types of variables were included in the first trimester risk surveillance: predictors and awareness  items7. 
The first type of factor was incorporated in the R4U-scorecard as predictive factor and will be referred to as ‘pre-
dictors’ (50 items). The original weighing of each predictor was based on the relative risk for adverse pregnancy 
outcomes (e.g. babies born preterm and/or SGA). The scores of the individual items ranged from 0 to 3 points and 
these were added up to form a cumulative score (range 0–98 points). The cumulative score of the R4U-scorecard 
was developed using a simple approach assuming that all features are conditionally independent of each other 
given the class, based on Bayes’  rule21. The initial cut-off score was based on data from a pilot study; a score of 
16 points or higher was selected to identify women in the upper 20% of risk  scores8,22. A score above this cut-off 
implied a follow-up action via a multidisciplinary consultation between involved care professionals guided by a 
particular single, or a set of multiple, risk  factors7.
Awareness items were incorporated to increase awareness for factors that could mediate the association 
between risk factors and adverse pregnancy outcomes, or to factors that are considered to be ‘red flags’ (26 
items)10,22. All awareness items are indications for additional consideration or evaluation, and these items do not 
have a score. Examples of potential mediators are: ‘irredeemable financial debts’, and ‘previous referral to youth 
social services’, and an example of a red flag is ‘having no health care insurance’.
participants. Participants in the intervention arm of the HP4All-1 risk screening C-RCT were included in 
the current study if the following data was available; (1) a completed R4U-scorecard and (2) pregnancy outcome 
data collected in the follow-up period.
Step 1. Data management and dealing with missing values. The primary outcome measure in the 
C-RCT was neonatal morbidity, defined as the combination of preterm birth (i.e. a delivery before 37 completed 
weeks of gestation), and/or having a SGA baby (i.e. a birth weight below the 10th centile adjusted for parity, ges-
tational age, and gender, based on the Dutch reference curves)23. We compared maternal, pregnancy, and prior-
pregnancy predictors in uncomplicated pregnancies with pregnancies followed by perinatal morbidity (Table 1).
Seven percent of the participants had at least one missing value within the predictor items, and complete case 
analysis would have reduced the total sample by 19%. A multiple imputation approach was therefore used to 
account for missing values in  predictors24. Predictor variables and outcome variables were included to inform the 
process, forming 20 datasets using multiple imputations with chained  equations25. Fifteen predictors with a low 
incidence were excluded from the multiple imputation process since this might have resulted in computational 
instability and unreliable estimates. We defined a low incidence as an incidence below 2% of the total sample 
size. The imputed data was then used to update the original prognostic model (step 3).
Step 2: Cross-validation of the original prognostic model. Cross-validation was based on the inclu-
sion date of participants within the HP4All-1  programme11. Participants before September 2014 were included 
in the development set and participants from September onward were included in the validation set. This date 
was chosen based on a second training session provided to all health care providers that implemented the R4U-
scorecard in routine practice. Domain validation was performed first on complete cases to test the generalis-
ability of the prognostic model across different domains, including participants from different health care set-
tings (i.e. community midwifery practices, secondary and tertiary hospital care)14. Validation was assessed with 
calibration plots and by computing the area under the receiver operating characteristic curve (AUC) with a 95% 
confidence interval (CI)26,27. Calibration was defined as the agreement between the probabilities of neonatal 
morbidity, as predicted by the prognostic model, and the observed frequencies. Discrimination was defined as 
the ability of the original model to distinguish between women who will have a preterm and/or SGA baby and 
those who will not. Sensitivity and specificity were calculated at the pre-specified cut-off R4U score of 16 points.
Step 3: Updating of the original prognostic model. The process of updating the original prognostic 
model consisted of four steps. The multiple imputed data was used to re-estimate the effect of each predictor in 
the model for  updating13. The development set was used to update the prognostic model. The validation set was 
used to test generalisability.
In the first step we determined which predictors were to be re-estimated by assessing their additional predic-
tive value on top of the cumulative R4U-score. Predictors that were assessed separately in the second trimester 
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of pregnancy were not evaluated (three items) and predictors that related to prior pregnancy characteristics were 
evaluated in multiparous women only (five items). A reference model was based on a univariate logistic regres-
sion model describing the association of the cumulative R4U-score with perinatal morbidity. Separate bivariate 
logistic regression models were constructed adding single predictors one at a time. Each nested, bivariate logistic 
regression model was tested separately against the reference model. Predictors were categorised as ‘candidate 
predictors’ if the p value of their association with adverse pregnancy outcomes independent of the total R4U score 
was below 0.20, with reference to the Wald test. Final selection of all candidate variables for the fully updated 
model was based on backward elimination of variables with a p value above 0.20.
In the second step a heuristic shrinkage factor was added to adjust β-coefficients of all included predictors 
for overfitting and to avoid extreme predictions when applied to new  participants13,28,29.
The shrinkage factor was estimated as  follows29: 
The number of degrees of freedom in this case is the total number of degrees of freedom that is considered 
in the process of selecting from all predictors, plus all covariates fitted in the model.
The third step consisted of an evaluation of the obtained multivariable model by exploring the β-coefficients 
and their corresponding sign and size. Because all predictors were initially incorporated in the R4U-scorecard 
based on their positive association with adverse pregnancy outcomes, a negative sign of the β-coefficient in the 
current multivariable model was considered counterintuitive. Counterintuitive signs observed in multivari-
able models can be explained by correlations between predictors and therefore careful evaluation of the model 
obtained is  necessary29. External information from recent literature and expert opinion was sought if a sign was 
counterintuitive in both univariate and multivariable analyses to finalise the model selection.
In the fourth and final step, we determined the additional effect of each predictor. Hereto we divided the 
β-coefficients obtained from the fully updated model, by the value of the coefficient corresponding with one 
point increase in the cumulative R4U-score, after shrinkage and evaluation of the sign had been accounted for.
Step 4: Assessing generalisability in the validation set using the updated model. To assess the 
predictive value of the updated model we used the validation set. Validation was assessed with calibration plots 
and by computing the area under the receiver operating characteristic curve. Sensitivity and specificity of the 
original and update score were compared in the validation set.
transparency declaration. The lead author affirms that this manuscript is an honest, accurate, and trans-
parent account of the study being reported; that no important aspects of the study have been omitted; and that 
any discrepancies from the study as planned (and, if relevant, registered) have been explained.
ethical consideration. The study was reviewed by the Medical Ethical Review Board of the Erasmus MC. 
All research was performed in accordance with the relevant regulations. The Board provided a waiver for the 
need to obtain consent at the individual level according to Dutch law as all procedures were essentially accepted 
care, and data were analysed anonymously (MEC-2012-322).
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on request.
Received: 5 September 2019; Accepted: 12 June 2020
References
 1. Marmot, M. et al. Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 372, 
1661–1669 (2008).
 2. Gissler, M. et al. Perinatal health monitoring in Europe: results from the EURO-PERISTAT project. Inform Health Soc Care 35, 
64–79 (2010).
 3. Vos, A. A., Posthumus, A. G., Bonsel, G. J., Steegers, E. A. & Denktas, S. Deprived neighborhoods and adverse perinatal outcome: 
a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand 93, 727–740 (2014).
 4. Gray, R. et al. Social inequalities in preterm birth in Scotland 1980–2003: findings from an area-based measure of deprivation. 
BJOG 115, 82–90 (2008).
 5. Weightman, A. L. et al. Social inequality and infant health in the UK: systematic review and meta-analyses. BMJ Open 2, 1 (2012).
 6. zorgverzekeringen, C. v. VERLOSKUNDIG VADEMECUM 2003 ’eindrapport van de Commissie Verloskunde van het College 
voor zorgverzekeringen’. (2003).
 7. Lagendijk, J. et al. Antenatal non-medical risk assessment and care pathways to improve pregnancy outcomes: a cluster randomised 
controlled trial. Eur. J. Epidemiol. 33, 579–589. https ://doi.org/10.1007/s1065 4-018-0387-7 (2018).
 8. Vos, A. A. et al. Effectiveness of score card-based antenatal risk selection, care pathways, and multidisciplinary consultation in the 
Healthy Pregnancy 4 All study (HP4ALL): study protocol for a cluster randomized controlled trial. Trials 16, 8 (2015).
 9. Denktas, S. et al. Design and outline of the Healthy Pregnancy 4 All study. BMC Pregnancy Childbirth 14, 253 (2014).
 10. Vos, A. A. et al. An instrument for broadened risk assessment in antenatal health care including non-medical issues. Int J Integr 
Care 15, e002 (2015).
 11. Steyerberg, E. W. & Harrell, F. E. Jr. Prediction models need appropriate internal, internal-external, and external validation. J Clin 
Epidemiol 69, 245–247 (2016).
Model χ2−
(




Scientific RepoRtS |        (2020) 10:11243  | https://doi.org/10.1038/s41598-020-68101-3
www.nature.com/scientificreports/
 12. Justice, A. C., Covinsky, K. E. & Berlin, J. A. Assessing the generalizability of prognostic information. Ann Intern Med 130, 515–524 
(1999).
 13. Steyerberg, E. W., Borsboom, G. J., van Houwelingen, H. C., Eijkemans, M. J. & Habbema, J. D. Validation and updating of predic-
tive logistic regression models: a study on sample size and shrinkage. Stat Med 23, 2567–2586 (2004).
 14. Toll, D. B., Janssen, K. J., Vergouwe, Y. & Moons, K. G. Validation, updating and impact of clinical prediction rules: a review. J Clin 
Epidemiol 61, 1085–1094 (2008).
 15. Kondo, N. Socioeconomic disparities and health: impacts and pathways. J Epidemiol 22, 2–6 (2012).
 16. Pillas, D. et al. Social inequalities in early childhood health and development: a European-wide systematic review. Pediatr Res 76, 
418–424 (2014).
 17. Chauvel, L. & Leist, A. K. Socioeconomic hierarchy and health gradient in Europe: the role of income inequality and of social 
origins. Int J Equity Health 14, 132 (2015).
 18. Steyerberg, E. W. & Vergouwe, Y. Towards better clinical prediction models: seven steps for development and an ABCD for valida-
tion. Eur Heart J 35, 1925–1931 (2014).
 19. van Voorst, S. F. et al. Effectiveness of general preconception care accompanied by a recruitment approach: protocol of a commu-
nity-based cohort study (the Healthy Pregnancy 4 All study). BMJ Open 5, 1 (2015).
 20. van Veen, M. J. et al. Feasibility and reliability of a newly developed antenatal risk score card in routine care. Midwifery 31, 147–154 
(2015).
 21. Cevenini, G. & Barbini, P. A bootstrap approach for assessing the uncertainty of outcome probabilities when using a scoring system. 
BMC Med Inform Decis Mak 10, 45 (2010).
 22. Posthumus, A. G., Birnie, E., van Veen, M. J., Steegers, E. A. & Bonsel, G. J. An antenatal prediction model for adverse birth out-
comes in an urban population: the contribution of medical and non-medical risks. Midwifery 38, 78–86 (2016).
 23. Visser, G. H., Eilers, P. H., Elferink-Stinkens, P. M., Merkus, H. M. & Wit, J. M. New Dutch reference curves for birthweight by 
gestational age. Early Hum. Dev. 85, 737–744 (2009).
 24. Vergouw, D. et al. The search for stable prognostic models in multiple imputed data sets. BMC Med. Res. Methodol. 10, 81–81. 
https ://doi.org/10.1186/1471-2288-10-81 (2010).
 25. Azur, M. J., Stuart, E. A., Frangakis, C. & Leaf, P. J. Multiple imputation by chained equations: what is it and how does it work?. 
Int. J. Methods Psychiatr. Res. 20, 40–49. https ://doi.org/10.1002/mpr.329 (2011).
 26. Cook, N. R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115, 928–935 (2007).
 27. Hosmer, D. W. & Lemesbow, S. Goodness of fit tests for the multiple logistic regression model. Commun. Stat. Theory Methods 9, 
1043–1069. https ://doi.org/10.1080/03610 92800 88279 41 (1980).
 28. Frank E, H., Kerry L, L. E. E. & Daniel B, M. (1996). Multivariable prognostic models: issues in developing mod-
els, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15, 361–387, doi:10.1002/
(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
 29. Steyerberg, E. W., Eijkemans, M. J., Harrell, F. E. Jr. & Habbema, J. D. Prognostic modelling with logistic regression analysis: a 
comparison of selection and estimation methods in small data sets. Stat Med 19, 1059–1079 (2000).
Acknowledgements
The research team would like to thank the participants and all participating organisations that generously shared 
their time, experience, and materials for the purposes of the ‘Healthy Pregnancy 4-All’ programme. The research 
team has received funding from the Ministry of Health, Welfare and Sports in order to execute the Healthy Preg-
nancy 4 All study (grant number 318 804). One author is supported by personal fellowships from the Erasmus 
MC and The Netherlands Lung Foundation (4.2.14.063JO).
Author contributions
Substantial contributions to the conception or design of the work (J.L., J.V.B., E.A.P.S., A.G.P.); or the acquisition 
(E.A.P.S.), analysis (J.L., E.W.S., A.G.P.), or interpretation of data for the work (J.L., E.W.S., L.A.D., J.V.B., E.A.P.S., 
A.G.P.). Drafting the work (J.L., L.A.D., A.G.P.) or revising it critically for important intellectual content (J.L., 
E.W.S., L.A.D., J.V.B., E.A.P.S., A.G.P.). Final approval of the version to be published (J.L., E.W.S., L.A.D., J.V.B., 
E.A.P.S., A.G.P.). Agreement to be accountable for all aspects of the work in ensuring that questions related to 
the accuracy or integrity of any part of the work are appropriately investigated and resolved (J.L., E.W.S., L.A.D., 
J.V.B., E.A.P.S., A.G.P.).
competing interests 
The authors declare no competing interests.
Additional information
Supplementary information  is available for this paper at https ://doi.org/10.1038/s4159 8-020-68101 -3.
Correspondence and requests for materials should be addressed to J.L.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this license, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
